Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Valeant's Relistor a future blockbuster? With AZ in the game, analysts aren't buying it

AZ frustrated with Tagrisso NICE delay, calls for reform

AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe

AstraZeneca's bid to protect Crestor fails as judge refuses to block new generics

AZ's Tagrisso trumps chemo in PhIII on its quest for $3B sales mark

AstraZeneca settles Sandoz patent fight over its top-selling cancer med

Judge sets late-breaking rules for AstraZeneca's last stand on Crestor

AZ could jump into the Medivation fray with $10B bid: Report

Medivation CEO to buyers: You'll pay top dollar for our 'best-in-class' PARP med

Medivation opens its books to would-be buyers, including the formerly hostile Sanofi